Lipodystrophy Syndromes.

Area of Science:

• Endocrinology and Metabolic Disorders

Background:

• Lipodystrophies encompass a group of rare disorders characterized by generalized or partial loss of adipose tissue.
• These conditions predispose individuals to significant metabolic complications.

Purpose of the Study:

• To provide a comprehensive overview of lipodystrophies, including their classification, associated metabolic abnormalities, and management strategies.

Main Methods:

• Review of existing literature on lipodystrophy classification (genetic vs. acquired, generalized vs. partial).
• Identification of common subtypes, including those induced by medications.
• Summary of characteristic metabolic derangements and current management approaches.

Main Results:

• Lipodystrophies are classified based on fat loss patterns and etiology (genetic or acquired).
• Common forms include congenital generalized lipodystrophy, familial partial lipodystrophy, acquired generalized lipodystrophy, and acquired partial lipodystrophy.
• Drug-induced lipodystrophies, such as those from highly active antiretroviral therapy, are also significant subtypes.

Conclusions:

• Lipodystrophies present with diverse clinical and genetic features, invariably leading to metabolic dysfunction.
• Key metabolic complications include insulin resistance, hypertriglyceridemia, and hepatic steatosis.
• Effective management is crucial for preventing and treating these metabolic sequelae.